Early Phase 1 Prostate Cancer Trial, Recruiting (NCT04857502)

Early Phase 1 Prostate Cancer Trial, Recruiting NCT04857502 Sponsor: Jonsson Comprehensive Cancer Center Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04857502 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with prostate cancer, either as a new diagnosis or as a cancer that has come back
People who have had a specific type of imaging scan called a 68Ga-PSMA-11 PET/CT scan to check the stage or restage of their prostate cancer
People whose 68Ga-PSMA-11 PET/CT scan showed signs of cancer in the lymph nodes
People who are already scheduled to have a surgical procedure to remove lymph nodes in the pelvic area
People who are able to give both verbal and written agreement to participate in the study
People who are able to follow the study's procedures and requirements

Who may not be able to join:

People who begin any prostate cancer treatment in the period between signing up for the study and having their surgery
People whose affected lymph nodes are located in a position that surgeons cannot safely reach (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Jeremie Calais, MD, UCLA / Jonsson Comprehensive Cancer Center

Phone: 310-206-7372

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04857502

Sponsor: Jonsson Comprehensive Cancer Center

Phase: Early Phase 1

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 310-206-7372

More information: https://clinicaltrials.gov/study/NCT04857502

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with prostate cancer, either as a new diagnosis or as a cancer that has come back
People who have had a specific type of imaging scan called a 68Ga-PSMA-11 PET/CT scan to check the stage or restage of their prostate cancer
People whose 68Ga-PSMA-11 PET/CT scan showed signs of cancer in the lymph nodes
People who are already scheduled to have a surgical procedure to remove lymph nodes in the pelvic area
People who are able to give both verbal and written agreement to participate in the study
People who are able to follow the study's procedures and requirements

Who may not be able to join:

People who begin any prostate cancer treatment in the period between signing up for the study and having their surgery
People whose affected lymph nodes are located in a position that surgeons cannot safely reach (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Jonsson Comprehensive Cancer Center

Registry

ClinicalTrials.gov

Start date

27 April 2021

Est. completion

1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The biodistribution of 99mTc-PSMA-I&S in normal and malignant tissues of patients with prostate cancer will be measured by average and maximum standardized uptake value (SUVmean and SUVmax)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov